Ad
related to: moderna
Search results
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 13 hours agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...
FDA approves Moderna's mRNA RSV vaccine for older adults
News Channel Nebraska· 54 minutes agoBy Jen Christensen, CNN
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 5 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 18 hours agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 4 days agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 23 hours agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31. "This approval ...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 5 days agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 6 days agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...